Acronym | Full name | Description |
ANCHOR | Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration | Phase 3 clinical trial in age-related macular degeneration |
BRAVO | Ranibizumab for the treatment of Macular Oedema Following Branch Retinal Vein Occlusion: Evaluation of Efficacy and Safety Trial | Phase 3 clinical trial in Branch Retinal Vein Occlusion (BRVO) |
CIGTS | Collaborative Initial Glaucoma Treatment Study | Medical versus surgical therapy trial in open-angle glaucoma |
COMET | Core Outcome Measures in Effectiveness Trials | An initiative to bring together people interested in the development and application of agreed standardised sets of outcomes, known as COS |
COS | Core Outcome Sets | An agreed minimum set of outcomes or outcome measures to be collected in all clinical studies of a particular condition |
COSMIN | Consensus-Based Standards for the Selection of Health Measurement Instruments | An initiative to improve the selection of health measurement instruments |
CRUISE | Central Retinal Vein Occlusion Study: Evaluation of Efficacy and Safety Trial | Phase 3 clinical trial in Central Retinal Vein Occlusion (CRVO) |
EAGLE | Effectiveness of Early Lens Extraction for the Treatment of Primary Angle-Closure Glaucoma | Surgical trial in primary angle-closure glaucoma |
FILMS | Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study | Surgical trial in macular-hole repair |
FVQ CYP | Functional Vision Questionnaire for Children and Young People | Questionnaire for the measurement of visual function in children and young people |
HTA | Health technology assessment | The systematic evaluation of the properties, effects and/or impacts of a health technology |
ICHOM | International Consortium for Health Outcomes Measurement | An initiative to try to measure and report patient outcomes in a standardised way |
ISOQOL | International Society for Quality of Life Research | An initiative to advance the study of health-related quality of life and other patient-centred outcomes |
IVAN | Inhibition of VEGF in Age-Related Choroidal Neovascularization | Randomised controlled trial in age-related macular degeneration |
MacDQol | Macular Disease on Quality of Life | An individualised measure of the impact of macular disease on quality of life |
MARINA | Minimally Classic/Occult Trial of the Anti-VEGF Antibody Ranibizumab in the Treatment of Neovascular AMD | Phase 3 clinical trial in age-related macular degeneration |
MUST | Multicentre Uveitis Steroid Treatment | Phase 4 clinical trial in uveitis |
NEI VFQ-25 | National Eye Institute Visual Functioning Questionnaire 25 | Questionnaire for the measurement of visual function in adults |
PREM | Patient-reported experience measure | A measurement instrument by which patients assess their experience of one or more aspects of their healthcare |
PROM | Patient-reported outcome measure | A measurement instrument by which patients assess their own health status, which may include symptoms, functionality and other aspects of physical, mental and social health |
PROQOLID | Patient-Reported Outcome Quality of Life Instruments Database | A database of patient-centred clinical outcome assessments |
PSS | Patient Support Society | An organisation that exists to support patients, usually outside the healthcare institutions |
RESTORE | Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema | Phase 3 trial in diabetic macular oedema |
VAQ | Visual Activities Questionnaire | Questionnaire of visual function in adults |
VQoL_CYP | Vision-Related Quality-of-Life Instrument for Children and Young People | Questionnaire for the measurement of vision-related quality of life in children and young people |